Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Scopus Biopharma Inc (SCPS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.002 0.000    0.00%
18/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.001 - 0.002
Scopus 0.002 0.000 0.00%

SCPS Balance Sheet

 
Featured here, the Balance Sheet for Scopus Biopharma Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
30/06
2023
31/03
2022
31/12
2022
30/09
Total Current Assets 0.496 1.6 0.39 0.413
Cash and Short Term Investments 0.362 1.4 0.125 0.311
Cash - - - -
Cash & Equivalents 0.362 1.4 0.125 0.311
Short Term Investments - - - -
Total Receivables, Net - - - -
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 0.134 0.2 0.265 0.102
Other Current Assets, Total - - - -
Total Assets 0.498 1.6 0.392 0.416
Property/Plant/Equipment, Total - Net 0.002 0.002 0.002 0.003
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - - - -
Other Assets, Total - - - -
Total Current Liabilities 11 9.31 7.45 5.92
Accounts Payable 0.173 0.19 0.176 0.111
Payable/Accrued - - - -
Accrued Expenses 10.74 8.96 7.03 5.81
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 0.093 0.161 0.253 -
Total Liabilities 11 9.31 7.45 5.92
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest -1.05 -0.763 -0.498 -
Other Liabilities, Total 1.05 0.763 0.498 -
Total Equity -10.5 -7.71 -7.06 -5.5
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.04 0.04 0.021 0.021
Additional Paid-In Capital 48.62 48.54 46.52 45.81
Retained Earnings (Accumulated Deficit) -58.13 -55.51 -53.06 -51.33
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -1.03 -0.778 -0.537 -0.003
Total Liabilities & Shareholders' Equity 0.498 1.6 0.392 0.416
Total Common Shares Outstanding 39.78 39.58 21.09 21.09
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SCPS Comments

Write your thoughts about Scopus Biopharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ahmed Boholaiga
Ahmed Boholaiga May 27, 2021 7:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$9.30
Liew ST
Liew ST May 27, 2021 4:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2021.05.27 JB @ $8.00
Cesar De Leon
Cesar De Leon Jan 29, 2021 4:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No Pulses need EKG
KJ KJ
KJ KJ Dec 18, 2020 4:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is going on here I don't understand
Gilles Nadon
Gilles Nadon Dec 17, 2020 10:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it opened at 21$ way too high. not worth this valuation
Gilles Nadon
Gilles Nadon Dec 17, 2020 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trading at 41$ this is crazy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email